%0 Journal Article
%T A Phase 2, Randomized, Placebo-Controlled Study Evaluating Matrix Metalloproteinase-9 Inhibitor, Andecaliximab, in Patients With Moderately to Severely Active Crohn’s Disease
%A Schreiber, Stefan
%A Siegel, Corey A
%A Friedenberg, Keith A
%A Younes, Ziad H
%A Seidler, Ursula
%A Bhandari, Bal R
%A Wang, Ke
%A Wendt, Emily
%A McKevitt, Matt
%A Zhao, Sally
%J Journal of Crohn's and Colitis
$V 12
%N 9
%P 1014-1020
%@ 1873-9946
%D 2018
%I Elsevier Science